---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-24-235949"
form_type: "8-K"
ticker: "OSRH"
cik: "0001840425"
company_name: "OSR Holdings, Inc."
filed_at: "2024-10-10T23:59:59+00:00"
generated_at: "2026-05-30T16:51:42.633658+00:00"
event_type: "regulatory"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Nasdaq panel grants Bellevue Life Sciences continued listing; must meet public holders rule by Feb 2025

## Summary
- Received Nasdaq notice Feb 2024 for failing minimum 300 public holders; plan approved with extension to Aug 13, 2024.
- Did not regain compliance by Aug 13; requested hearing which stayed suspension.
- Hearing held Oct 1, 2024; Panel granted continued listing on Oct 4, 2024.
- Must demonstrate compliance with Listing Rule 5505 by Feb 17, 2025, with prompt notification.

## SEC filing metadata
- accession: 0001193125-24-235949
- form_type: 8-K
- ticker: OSRH
- cik: 0001840425
- company_name: OSR Holdings, Inc.
- filed_at: 2024-10-10T23:59:59+00:00
- event_type: regulatory
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 3.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1840425/000119312524235949/0001193125-24-235949-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1840425/000119312524235949/d846929d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-24-235949
- JSON: https://secwatch.observer/filing/0001193125-24-235949.json
- Plain text: https://secwatch.observer/filing/0001193125-24-235949.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.